Free Consultation | (800) 259-9010 International via WhatsApp: 713-227-2400 (text only)
San Francisco Hedge Fund Files Securities Fraud Lawsuit Against Blood Testing Company Theranos
The Wall Street Journal and other media are reporting that Theranos is now the defendant of a securities fraud lawsuit brought by one of its major investors. The plaintiff is San Francisco hedge fund Partner Fund Management, which is one of the blood testing company’s largest financial backers. Partner, which brought its case in the Delaware Court of Chancery, is seeking damages beyond its investment and costs related to the lawsuit.
Although the complaint is under seal, Partner has confirmed that it has brought a legal case against the beleaguered blood testing company. According to a letter, which the hedge fund sent to investors, Theranos took part in “lies, material misstatements, and omissions” to persuade Partner to invest in the company. The letter notes that Theranos CEO/founder Elizabeth Holmes and ex-President Sunny Balwani are also defendants in the case.
Partner Fund believes that Holmes was deceptive when claiming that Theranos’s proprietary technologies were working and close to receiving regulatory approvals. Meantime, Theranos has stated that it would combat the securities fraud lawsuit.